Further, we examined the association between RTN4 rs34917480 and clinicopathological features of BC, including the age and tumor size at the time of diagnosis, histological subtype, grade and stage, and the status of estrogen receptor (ER), progesterone receptor (PR), and HER2 receptors of patients. This evidence concerns the gene RTN4 and breast cancer.